Previous Page  5 / 29 Next Page
Information
Show Menu
Previous Page 5 / 29 Next Page
Page Background

Page 81

Notes:

Journal of Gastrointestinal & Digestive System | ISSN: 2161-069X | Volume: 8

&

&

October 29-30, 2018 | San Francisco, USA

International Conference on

Gastrointestinal Cancer and Therapeutics

4

th

World Congress on

Digestive & Metabolic Diseases

26

th

Annual Congress on

Cancer Science and Targeted Therapies

Effects of white bean flour (

Phaseolus vulgaris

) on intestinal mucosa: Food safety assessment

Patrízia Mello Coelho

1

, Daniel Silva Sena Bastos

2

, Patrick Fernandes da Silva

3

, Silvia Almeida Cardoso

4

, Leandro Licursi de Oliveira

2

and

Wendeo

Ferreira da Silveira

2

1

Instituto Federal de Minas Gerais, Brazil

2

Universidade Federal de Viçosa, Brazil

3

Faculdade de Medicina de Ribeirão Preto, Brazil

4

Universidade Federal de Viçosa, Brazil

B

ean (

Phaseolus vulgaris

) "in natura" supplementation has been indicated for fat burning, reduced appetite, and weight

loss. However, there are reports of risks to health arising from its use. This study evaluated the food safety of white bean

flour as a dietary supplement. Mice were divided into three experimental groups (n=10) and 0.5ml of white bean flour extract

(WBFE) were orally administered daily at two concentrations: Group 1 (2.65g/kg), Group 2 (5.30g/kg) and control (PBS) for

14 days. Half of the animals were euthanized on day 14 to assess acute exposure and half on day 28 to assess lesion recovery.

The small intestine was collected for histological analysis, dosage cytokines (TNF, IFN-γ, IL-12, IL-4, IL-6, IL-10 and MCP-

1), and antioxidant enzymes (CAT, SOD, and MDA). The animals WBFE-treated groups had a decrease in body weight and

glycemia in a dose-dependent manner. There was a reduction in the height of the intestinal villi and an increase in the depth

of the crypts. Animals from group 2 (5.30g/kg WBFE) presented mononuclear inflammatory infiltrate in the intestinal mucosa

and increased MCP-1 and NO. SOD, CAT, and MDA were higher in the treated groups, however, no difference in relation to

control. Animals presented repair their intestinal mucosa, reestablishment of glycemia and the increase of weight gain in the

absence of WBFE. The WBFE showed antinutritional and immunomodulatory effects, therefore, it is not safe as oral dietary

supplementation at the dosages used.

Biography

Wendeo Ferreira da Silveira completes biological sciences course at Santa Marcelina University. He started at Universidade Federal de Viçosa–UFV in 2012.

Ended PhD in 2018. He currently coordinates the immunochemistry and glycobiology laboratory of the same institution. It acts in the areas immunotherapy for

experimental Chagas disease, protein-carbohydrate and protein-protein interaction in infections by intracellular pathogens, identification and characterization of

new lectins, IgY microencapsulation for veterinary use, prospecting of biomolecules with antimicrobial and antiparasitic activity, glycobiology of venoms.

deosilveira@yahoo.com.br

Patrízia Mello Coelho et al., J Gastrointest Dig Syst 2018, Volume 8

DOI: 10.4172/2161-069X-C8-086